{"podcast":{"title":"The BioHub - by Avetix","slug":"the-biohub-by-avetix-7252289","podcast_index_feed_id":7252289,"rss_url":"https://anchor.fm/s/f0076084/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/max-brennan4","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40170153/40170153-1775724702970-e7a36a5e3cf58.jpg","author":"Max Brennan - Biotech HeadHunter","episode_count":230,"summary":"Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that's shaping the future of biotechnology. Get ready for an immersive experience into the world of biotech with The BioHub.","last_synced_at":"2026-07-21T04:19:24.893516+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289"},"episode":{"title":"Episode 160 - Elizabeth Jeffords - CEO at Iolyx Therapeutics","slug":"episode-160-elizabeth-jeffords-ceo-at-iolyx-therapeutics","published_at":"2026-04-23T09:50:38+00:00","page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-160-elizabeth-jeffords-ceo-at-iolyx-therapeutics","show_page_url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289","url":"https://podcasters.spotify.com/pod/show/max-brennan4/episodes/Episode-160---Elizabeth-Jeffords---CEO-at-Iolyx-Therapeutics-e3ibggh","audio_url":"https://anchor.fm/s/f0076084/podcast/play/118915025/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-3-23%2F422687376-44100-2-02897ffa08439.mp3","summary":"Today, we’re joined by a leader working at the cutting edgeof immunology and eye disease. Elizabeth Jeffords is the CEO of Iolyx Therapeutics, a clinical-stage biotech company focused on transforming how we treat inflammatory and autoimmune diseases of the eye. Iolyx sits at the emerging intersection of immunology andophthalmology—what’s often called immuno-ophthalmology. The company is developing targeted therapies designed to treat ocular inflammation right at its source, with the goal of replacing older treatments like steroids and broadimmunosuppressants with more precise, better-tolerated options. Their lead program is a topical immunomodulatory therapy forautoimmune dry eye disease, which has already shown promising results in Phase 2 clinical trials—demonstrating meaningful improvements in ocular surface health for patients with underlying inflammatory conditions. In today’s conversation, we’ll explore how her career led her into biotech leadership, why the eye is such a unique and challenging organ for drug development, the Biotech CEO sisterhood and how immunology could reshape the future of treating chronic eye disease.","meta_description":"Today, we’re joined by a leader working at the cutting edgeof immunology and eye disease. Elizabeth Jeffords is the CEO of Iolyx Therapeutics, a clinical-…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1595,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-biohub-by-avetix-7252289/episodes/episode-160-elizabeth-jeffords-ceo-at-iolyx-therapeutics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-biohub-by-avetix-7252289/episode-160-elizabeth-jeffords-ceo-at-iolyx-therapeutics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}